Chimeric Therapeutics Limited
CHMMF
$0.001
-$0.029-96.67%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 3.14M | 3.51M | 2.04M | 1.99M | 2.40M |
Total Receivables | 1.22M | 1.36M | 57.80K | 56.50K | 6.51M |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 75.30K | 84.40K | 55.00K | 53.80K | 732.90K |
Total Current Assets | 4.43M | 4.96M | 2.15M | 2.10M | 9.65M |
|
|||||
Total Current Assets | 4.43M | 4.96M | 2.15M | 2.10M | 9.65M |
Net Property, Plant & Equipment | -- | -- | 500.00 | 400.00 | 1.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 7.13M | 7.99M | 8.01M | 7.83M | 8.52M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 11.56M | 12.95M | 10.19M | 9.96M | 18.19M |
|
|||||
Total Accounts Payable | 3.84M | 4.30M | 2.14M | 2.09M | 3.44M |
Total Accrued Expenses | 845.40K | 947.10K | 2.16M | 2.11M | 1.32M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 1.64M | 1.84M | 2.44M | 2.39M | 2.19M |
Total Other Current Liabilities | 1.64M | 1.84M | 2.44M | 2.39M | 2.19M |
Total Current Liabilities | 6.33M | 7.09M | 6.74M | 6.58M | 6.95M |
|
|||||
Total Current Liabilities | 6.33M | 7.09M | 6.74M | 6.58M | 6.95M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.55M | 1.74M | 1.81M | 1.76M | 1.80M |
Total Liabilities | 7.88M | 8.83M | 8.54M | 8.35M | 8.74M |
|
|||||
Common Stock & APIC | 42.38M | 47.48M | 42.37M | 41.42M | 40.82M |
Retained Earnings | -42.96M | -48.13M | -44.41M | -43.40M | -36.13M |
Treasury Stock & Other | 4.25M | 4.76M | 3.68M | 3.60M | 4.75M |
Total Common Equity | 3.68M | 4.12M | 1.65M | 1.61M | 9.45M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 3.68M | 4.12M | 1.65M | 1.61M | 9.45M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 3.68M | 4.12M | 1.65M | 1.61M | 9.45M |
|